Inventor
LOIBNER HANS
AT32 patents
⚠️ This page may combine multiple inventors who share the name “LOIBNER HANS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
APEIRON BIOLOGICS AG
8 patentsUS10294305B2May 21, 2019
Method for treating a GD2 positive cancer
APEIRON BIOLOGICS AG20 citations90
US9840566B2Dec 12, 2017
Preparations and methods for treating a GD2 positive cancer
APEIRON BIOLOGICS AG7 citations80
US11597775B2Mar 7, 2023
Preparations and methods for treating a GD2 positive cancer
APEIRON BIOLOGICS AG0 citations59
US11492412B2Nov 8, 2022
Preparations and methods for treating a GD2 positive cancer
APEIRON BIOLOGICS AG0 citations59
US10995147B2May 4, 2021
Preparations and methods for treating a GD2 positive cancer
APEIRON BIOLOGICS AG0 citations59
US11447565B2Sep 20, 2022
Method for treating a GD2 positive cancer
APEIRON BIOLOGICS AG0 citations57
US10716833B2Jul 21, 2020
Method for producing ACE2 polypeptide
APEIRON BIOLOGICS AG0 citations48
US10472341B2Nov 12, 2019
Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases
APEIRON BIOLOGICS AG0 citations32
LOIBNER HANS
6 patentsUS9561263B2Feb 7, 2017
Treatment of inflammatory illnesses with ACE2
LOIBNER HANS11 citations83
US8241864B2Aug 14, 2012
Method for determining ACE2 activity
LOIBNER HANS10 citations82
US9777068B2Oct 3, 2017
Method for treating a GD2 positive cancer
LOIBNER HANS17 citations78
US6956119B2Oct 18, 2005
Polysaccharide-polypeptide conjugate
LOIBNER HANS4 citations60
US8062625B2Nov 22, 2011
Cancer immunotherapy predictive parameters
LOIBNER HANS0 citations51
US8153135B2Apr 10, 2012
Polysaccharide-polypeptide conjugate
LOIBNER HANS0 citations49
SANDOZ LTD
3 patentsUS5562903AOct 8, 1996
Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2
SANDOZ LTD69 citations91
US4503046AMar 5, 1985
1-Nitro-aminoglycoside derivatives, pharmaceutical compositions containing them and such derivatives for use as pharmaceuticals
SANDOZ LTD10 citations70
US5523085AJun 4, 1996
Monoclonal antibody in destruction of small cell lung carcinoma
SANDOZ LTD2 citations62
IGENEON KREBS IMMUNTHERAPIE
3 patentsUS7527789B2May 5, 2009
Use of a preparation based on an antibody directed against a tumor-associated glycosylation
IGENEON KREBS IMMUNTHERAPIE9 citations78
US8034338B2Oct 11, 2011
Immunogenic recombinant antibody
IGENEON KREBS IMMUNTHERAPIE4 citations57
US7691372B2Apr 6, 2010
Use of antibodies for the vaccination against cancer
IGENEON KREBS IMMUNTHERAPIE0 citations48
SCHUSTER MANFRED
2 patentsATTOQUANT DIAGNOSTICS GMBH
2 patentsUS11079398B2Aug 3, 2021
Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples
ATTOQUANT DIAGNOSTICS GMBH0 citations57
US9839668B2Dec 12, 2017
Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
ATTOQUANT DIAGNOSTICS GMBH1 citations45